Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2271 |
|
| Actual shortage: | 53 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2199 (97%) | |
Discontinuation Reports |
124 |
|
| To be discontinued: | 4 (3%) | |
| Discontinued: | 118 (95%) | |
| Reversed: | 2 (2%) | |
Late reports |
452 (19%) |
|
Overdue reports |
11 (19%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-08-21 | 2023-11-13 | 202538 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-09-05 | 2023-10-17 | 203653 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-11-20 | 2024-01-17 | 210838 |
| SANDOZ DAPAGLIFLOZIN | 5MG | TABLET | Resolved | 2023-12-19 | 2024-01-04 | 213801 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-01-16 | 2024-02-06 | 216168 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-03-05 | 2024-05-14 | 221380 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-07-02 | 2024-08-13 | 231744 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2025-05-05 | 2025-05-27 | 256661 |
| SANDOZ DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Resolved | 2020-01-08 | 2020-03-30 | 102568 |
| SANDOZ DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Resolved | 2021-12-30 | 2022-01-18 | 151976 |
| SANDOZ DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Resolved | 2023-06-05 | 2023-10-24 | 193710 |
| SANDOZ DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Resolved | 2023-09-19 | 2023-11-14 | 204727 |
| SANDOZ DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2022-02-17 | 2022-02-25 | 155256 |
| SANDOZ DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2024-04-23 | 2024-06-26 | 225962 |
| SANDOZ DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2024-11-25 | 2025-04-22 | 243843 |
| SANDOZ DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2025-01-13 | 2025-04-22 | 247593 |
| SANDOZ DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2025-04-07 | 2025-04-22 | 254335 |
| SANDOZ DICLOFENAC OPHTHA | 0.1% | SOLUTION | Resolved | 2020-03-30 | 2020-08-24 | 110109 |
| SANDOZ DICLOFENAC OPHTHA | 0.1% | SOLUTION | Resolved | 2020-12-21 | 2021-01-12 | 130505 |
| SANDOZ DICLOFENAC OPHTHA | 0.1% | SOLUTION | Resolved | 2022-06-03 | 2022-06-09 | 161791 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Discontinued | 2021-09-02 | 2021-09-02 | 145015 |
| VITAMIN B12 | 100MCG | LIQUID | Discontinued | 2017-06-06 | 2017-07-01 | 12133 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |